BACE1 and Alzheimer disease: Chen et al found that levels of nuclear factor kappa-B (NF-κB) p65 and BACE1 were higher in brains of patients with AD, and also showed that BACE1 gene expression and APP metabolism were facilitated by NF-κB p65 (Chen et al., 2012).